Is ADVB or BIAF more undervalued in 2026?

CirclFi compares Advanced Biomed Inc. (ADVB) and bioAffinity Technologies, Inc. (BIAF) using 13 institutional-grade valuation models. ADVB has a Quality of Company score of 5.7/10 while BIAF scores 4.7/10.

Which is a better buy — ADVB or BIAF?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ADVB and BIAF valuations compare?

ADVB at $3.91 and BIAF at $1.65 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ADVB vs BIAF Valuation Comparison 2026 — Intrinsic Value Analysis

ADVB

Diagnostics & Research

Advanced Biomed Inc.

Quality

5.7

out of 10

Value Trap

—

Price

$3.91

Last close

Models

5/13

Active

BIAF

Diagnostics & Research

bioAffinity Technologies, Inc.

Quality

4.7

out of 10

Value Trap

WARN

Price

$1.65

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	ADVB Fair Value	ADVB Upside	BIAF Fair Value	BIAF Upside
Bayesian DCF	Intrinsic	$20.02	+411.9%	$0.71	-56.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	—	—	$0.18	-91.8%
Dynamic NAV	Asset-Based	$3.46	-11.4%	$1.22	-26.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ADVB vs BIAF — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ADVB vs BIAF — Which Stock Is More Undervalued?

ADVB scores higher with a 5.7/10 quality rating vs BIAF's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Advanced Biomed Inc. (ADVB) and bioAffinity Technologies, Inc. (BIAF) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ADVB currently trades at $3.91 with a QOC of 5.7/10, while BIAF trades at $1.65 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).